Skip to main content

THIS END UP DEPAKOTE SPRINKLE 125 mg Pill - blue & white capsule/oblong, 17mm

Generic Name: divalproex sodium

Pill with imprint THIS END UP DEPAKOTE SPRINKLE 125 mg is Blue & White, Capsule/Oblong and has been identified as Depakote Sprinkles 125 mg. It is supplied by Abbott Laboratories.

Depakote Sprinkles is used in the treatment of Seizures; Epilepsy and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Depakote Sprinkles 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for THIS END UP DEPAKOTE SPRINKLE 125 mg

Depakote sprinkles 125 mg THIS END UP DEPAKOTE SPRINKLE 125 mg
Depakote sprinkles 125 mg THIS END UP DEPAKOTE SPRINKLE 125 mg
Depakote sprinkles 125 mg THIS END UP DEPAKOTE SPRINKLE 125 mg

Depakote Sprinkles

Generic Name
divalproex sodium
Imprint
THIS END UP DEPAKOTE SPRINKLE 125 mg
Strength
125 mg
Color
Blue & White
Size
17.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Fatty acid derivative anticonvulsants
Pregnancy Category
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule
Not a controlled drug
Labeler / Supplier
Abbott Laboratories
Inactive Ingredients
silicon dioxide, triethyl citrate, magnesium stearate, D&C Red No. 28, FD&C Blue No. 1, ferric oxide red, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00074-6114 Abbott Laboratories
00781-2243 (Discontinued) Sandoz Inc.
55289-0991 PDRX Pharmaceuticals Inc. (repackager)
49999-0942 Lake Erie Medical and Surgical Supply (repackager)

Get help with Imprint Code FAQs.

Related images for "THIS END UP DEPAKOTE SPRINKLE 125 mg"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.